President Donald J. Trump will visit the Research Triangle Park today. He’s seen here at a ribbon cutting ceremony in 2019, at the Louis Vuitton Workshop- Rochambeau in Texas. (Official White House Photo by Shealah Craighead)

July 27. President Donald Trump will visit the Fujifilm Diosynth Biotechnologies’ Innovation Center in the Research Triangle Park today. The company is helping with the manufacturing of components for a potential vaccine developed by Novavax. That vaccine is expected to be in Phase 2 clinical trials by the middle of August.

As of Sunday, North Carolina had recorded 112,713 cases of COVID-19 and 1,785 deaths.

It’s part of Operation Warp Speed, the federal government’s effort to ramp up COVID-19 vaccines and treatments as quickly as possible.

Fujifilm Diosynth is a leading biologics-Contract Development and Manufacturing Organization (CDMO) that is also part of the COVID-19 Therapeutics Accelerator, an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed up the response to the global pandemic.

“COVID-19 has had a profound impact on the global community. With the goal of enhancing society through innovation, Fujiifilm and the various Fujifilm businesses globally are committed to support the fight against COVID-19,” said CEO Martin Meeson. “We are honored that FUJIFILM Diosynth Biotechnologies is able to use its resources to support COVID-19 Therapeutics Accelerator partners in their mission to improve health.”